Sexual Dysfunction with Lexapro (Escitalopram) Compared to Other SSRIs
Lexapro (escitalopram) has significant rates of sexual dysfunction similar to other SSRIs, with approximately 7% of patients experiencing decreased libido and 12-14% of males experiencing ejaculatory disorders, though these rates are likely underreported. 1
Comparative Rates of Sexual Dysfunction Among Antidepressants
- Sexual dysfunction is a common side effect of SSRIs, with significant differences in incidence among medications 2
- According to FDA labeling for escitalopram, sexual side effects include:
- These rates are likely underreported as patients and physicians may be reluctant to discuss sexual side effects 1, 2
- Paroxetine has higher rates of sexual dysfunction than fluoxetine, fluvoxamine, and sertraline 2
- Fluoxetine is associated with particularly high rates of sexual dysfunction, with reported rates between 57.7% and 62.9% 3
- Among SSRIs as a class, sexual dysfunction rates range from 36-43%, significantly higher than non-SSRI alternatives 4
Non-SSRI Alternatives with Lower Sexual Side Effect Profiles
- Bupropion has significantly lower rates of sexual adverse events (22-25%) compared to SSRIs and should be considered as a first-line alternative when sexual side effects are a concern 2, 4
- In a prospectively defined population without predisposing factors for sexual dysfunction, the odds of experiencing sexual dysfunction were 4-6 times greater with SSRIs compared to bupropion SR 4
- Mirtazapine and nefazodone (28%) are associated with lower rates of sexual dysfunction than SSRIs 4, 5
- Vortioxetine has shown significantly greater improvements in sexual functioning compared to escitalopram in patients with SSRI-induced sexual dysfunction 6
Types of Sexual Dysfunction with Escitalopram
- The most common sexual side effects with escitalopram include:
Management Options for SSRI-Induced Sexual Dysfunction
- For patients requiring antidepressant therapy where sexual dysfunction is a significant concern, bupropion should be considered as a first-line agent 2
- Switching from an SSRI to escitalopram may help in some cases, though evidence is limited 7
- Switching to vortioxetine has shown benefits for patients experiencing sexual dysfunction during SSRI therapy 6
- Buspirone has been studied as a potential off-label treatment option for sexual dysfunction, particularly for low desire or libido 2
Important Clinical Considerations
- Sexual dysfunction is a leading cause of medication non-adherence in antidepressant therapy 5
- Post-SSRI sexual dysfunction has been identified as a potential, although rare, adverse effect that may persist after discontinuation of the drug 5
- Physicians consistently underestimate the prevalence of antidepressant-associated sexual dysfunction, making active assessment essential 4
- Sexual function should be actively assessed at baseline, at regular intervals during treatment, and after treatment cessation 5